These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 36347992)

  • 1. Kidney function measures and cardiovascular outcomes in people with diabetes: the Hoorn Diabetes Care System cohort.
    Dal Canto E; Elders PJM; van der Heijden AA; van Ballegooijen AJ; Lissenberg-Witte BI; Rutters F; Beulens JWJ
    Diabetologia; 2023 Mar; 66(3):482-494. PubMed ID: 36347992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney Function as Risk Factor and Predictor of Cardiovascular Outcomes and Mortality Among Older Adults.
    Kühn A; van der Giet M; Kuhlmann MK; Martus P; Mielke N; Ebert N; Schaeffner ES
    Am J Kidney Dis; 2021 Mar; 77(3):386-396.e1. PubMed ID: 33197533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalbuminuric Diabetic Kidney Disease and Risk of All-Cause Mortality and Cardiovascular and Kidney Outcomes in Type 2 Diabetes: Findings From the Hong Kong Diabetes Biobank.
    Jin Q; Luk AO; Lau ESH; Tam CHT; Ozaki R; Lim CKP; Wu H; Jiang G; Chow EYK; Ng JK; Kong APS; Fan B; Lee KF; Siu SC; Hui G; Tsang CC; Lau KP; Leung JY; Tsang MW; Kam G; Lau IT; Li JK; Yeung VT; Lau E; Lo S; Fung S; Cheng YL; Chow CC; Huang Y; Lan HY; Szeto CC; So WY; Chan JCN; Ma RCW;
    Am J Kidney Dis; 2022 Aug; 80(2):196-206.e1. PubMed ID: 34999159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of estimated glomerular filtration rate and urine albumin-to-creatinine ratio with incidence of cardiovascular diseases and mortality in chinese patients with type 2 diabetes mellitus - a population-based retrospective cohort study.
    Fung CS; Wan EY; Chan AK; Lam CL
    BMC Nephrol; 2017 Feb; 18(1):47. PubMed ID: 28152985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Finerenone and Heart Failure Outcomes by Kidney Function/Albuminuria in Chronic Kidney Disease and Diabetes.
    Filippatos G; Anker SD; Pitt B; Rossing P; Joseph A; Kolkhof P; Lambelet M; Lawatscheck R; Bakris GL; Ruilope LM; Agarwal R
    JACC Heart Fail; 2022 Nov; 10(11):860-870. PubMed ID: 36328655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Dapagliflozin on Cardiovascular Outcomes According to Baseline Kidney Function and Albuminuria Status in Patients With Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Zelniker TA; Raz I; Mosenzon O; Dwyer JP; Heerspink HHJL; Cahn A; Goodrich EL; Im K; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Gause-Nilsson I; Langkilde AM; Sabatine MS; Wiviott SD
    JAMA Cardiol; 2021 Jul; 6(7):801-810. PubMed ID: 33851953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Kidney Disease Stage and Cardiovascular and Mortality Events Among Older Adults: The SPRINT Trial.
    Turbay-Caballero V; Ricardo AC; Chen J; Missikpode C; Lash JP; Aroca-Martinez G; Musso CG
    Kidney Med; 2024 Jul; 6(7):100845. PubMed ID: 38966681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis.
    ; Grams ME; Coresh J; Matsushita K; Ballew SH; Sang Y; Surapaneni A; Alencar de Pinho N; Anderson A; Appel LJ; Ärnlöv J; Azizi F; Bansal N; Bell S; Bilo HJG; Brunskill NJ; Carrero JJ; Chadban S; Chalmers J; Chen J; Ciemins E; Cirillo M; Ebert N; Evans M; Ferreiro A; Fu EL; Fukagawa M; Green JA; Gutierrez OM; Herrington WG; Hwang SJ; Inker LA; Iseki K; Jafar T; Jassal SK; Jha V; Kadota A; Katz R; Köttgen A; Konta T; Kronenberg F; Lee BJ; Lees J; Levin A; Looker HC; Major R; Melzer Cohen C; Mieno M; Miyazaki M; Moranne O; Muraki I; Naimark D; Nitsch D; Oh W; Pena M; Purnell TS; Sabanayagam C; Satoh M; Sawhney S; Schaeffner E; Schöttker B; Shen JI; Shlipak MG; Sinha S; Stengel B; Sumida K; Tonelli M; Valdivielso JM; van Zuilen AD; Visseren FLJ; Wang AY; Wen CP; Wheeler DC; Yatsuya H; Yamagata K; Yang JW; Young A; Zhang H; Zhang L; Levey AS; Gansevoort RT
    JAMA; 2023 Oct; 330(13):1266-1277. PubMed ID: 37787795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal Effects and Associated Outcomes During Angiotensin-Neprilysin Inhibition in Heart Failure.
    Damman K; Gori M; Claggett B; Jhund PS; Senni M; Lefkowitz MP; Prescott MF; Shi VC; Rouleau JL; Swedberg K; Zile MR; Packer M; Desai AS; Solomon SD; McMurray JJV
    JACC Heart Fail; 2018 Jun; 6(6):489-498. PubMed ID: 29655829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone.
    Agarwal R; Pitt B; Rossing P; Anker SD; Filippatos G; Ruilope LM; Kovesdy CP; Tuttle K; Vaduganathan M; Wanner C; Bansilal S; Gebel M; Joseph A; Lawatscheck R; Bakris GL
    JAMA Cardiol; 2023 Aug; 8(8):732-741. PubMed ID: 37314801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Empagliflozin Treatment With Albuminuria Levels in Patients With Heart Failure: A Secondary Analysis of EMPEROR-Pooled.
    Ferreira JP; Zannad F; Butler J; Filippatos G; Pocock SJ; Brueckmann M; Steubl D; Schueler E; Anker SD; Packer M
    JAMA Cardiol; 2022 Nov; 7(11):1148-1159. PubMed ID: 36129693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of Early Kidney Disease With Brain Magnetic Resonance Imaging and Cognitive Function in African Americans With Type 2 Diabetes Mellitus.
    Freedman BI; Sink KM; Hugenschmidt CE; Hughes TM; Williamson JD; Whitlow CT; Palmer ND; Miller ME; Lovato LC; Xu J; Smith SC; Launer LJ; Barzilay JI; Cohen RM; Sullivan MD; Bryan RN; Wagner BC; Bowden DW; Maldjian JA; Divers J;
    Am J Kidney Dis; 2017 Nov; 70(5):627-637. PubMed ID: 28648301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic kidney disease and risk of incident stroke among adults with type 2 diabetes.
    Kaze AD; Jaar BG; Fonarow GC; Echouffo-Tcheugui JB
    BMC Med; 2022 Mar; 20(1):127. PubMed ID: 35346165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of heart failure events with intensive versus standard blood pressure lowering across the spectrum of kidney function and albuminuria: a SPRINT substudy.
    Vaduganathan M; Pareek M; Kristensen AMD; Biering-Sørensen T; Byrne C; Almarzooq Z; Olesen TB; Olsen MH; Bhatt DL
    Eur J Heart Fail; 2021 Mar; 23(3):384-392. PubMed ID: 33448580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimated glomerular filtration rate and urinary albumin excretion are independently associated with greater arterial stiffness: the Hoorn Study.
    Hermans MM; Henry R; Dekker JM; Kooman JP; Kostense PJ; Nijpels G; Heine RJ; Stehouwer CD
    J Am Soc Nephrol; 2007 Jun; 18(6):1942-52. PubMed ID: 17460143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes.
    Wada T; Haneda M; Furuichi K; Babazono T; Yokoyama H; Iseki K; Araki S; Ninomiya T; Hara S; Suzuki Y; Iwano M; Kusano E; Moriya T; Satoh H; Nakamura H; Shimizu M; Toyama T; Hara A; Makino H;
    Clin Exp Nephrol; 2014 Aug; 18(4):613-20. PubMed ID: 24132561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes.
    Nichols GA; Déruaz-Luyet A; Brodovicz KG; Kimes TM; Rosales AG; Hauske SJ
    BMC Nephrol; 2020 May; 21(1):167. PubMed ID: 32380961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.
    Jongs N; Greene T; Chertow GM; McMurray JJV; Langkilde AM; Correa-Rotter R; Rossing P; Sjöström CD; Stefansson BV; Toto RD; Wheeler DC; Heerspink HJL;
    Lancet Diabetes Endocrinol; 2021 Nov; 9(11):755-766. PubMed ID: 34619106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular Effects of Canagliflozin in Relation to Renal Function and Albuminuria.
    Sarraju A; Bakris G; Cannon CP; Cherney D; Damaraju CV; Figtree GA; Gogate J; Greene T; Heerspink HJL; Januzzi JL; Neal B; Jardine MJ; Blais J; Kosiborod M; Levin A; Lingvay I; Weir MR; Perkovic V; Mahaffey KW
    J Am Coll Cardiol; 2022 Nov; 80(18):1721-1731. PubMed ID: 36302584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of Chronic Kidney Disease Risk Categories and Risk of Cardiovascular Disease and Total Mortality: Coronary Artery Risk Development in Young Adults Cohort.
    Choi Y; Jacobs DR; Shroff GR; Kramer H; Chang AR; Duprez DA
    J Am Heart Assoc; 2022 Nov; 11(21):e026685. PubMed ID: 36314497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.